Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies
about
On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug MonitoringPractice Update: Review of Anticonvulsant Therapy.In vivo Raman measurement of levofloxacin lactate in blood using a nanoparticle-coated optical fiber probe.Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.Clinical applications of CYP genotyping in psychiatry.The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.Three patients needing high doses of valproic Acid to get therapeutic concentrationsPhenoconversion and therapeutic drug monitoring.Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs.Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatry.Interactions between cannabidiol and commonly used antiepileptic drugs.Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs.Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.PharmGKB summary: clobazam pathway, pharmacokinetics.Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy
P2860
Q27024074-8C423B9F-7106-46FE-AA6B-D18E055A251EQ34518509-C92C9EB2-2BA9-412A-9E62-D835CB583D4DQ36899684-537836CC-443B-4422-B9E8-309306D23971Q38152329-14569A9B-0A29-4B6A-80CA-EA2E8867997BQ38247063-B5CABD5B-7FC8-4968-B547-FC94B33BBAFBQ38621010-DC3A1BEE-004C-4834-9219-9479B95B1BBCQ40523894-3752D8D2-1F6F-49E3-A037-27C92B5CEB03Q43157879-42A07AAF-53CB-4590-885D-C6DDF60F94FDQ45250005-A36CA36C-7D1D-4720-9DA9-4CD4B7A664F5Q48162906-D1998285-3B65-47B8-AD67-A47D8E605F95Q48283873-07F0E4FE-C382-4C1A-9655-AAE6F9B3D5BDQ48363733-6C2204F7-AF71-4E84-9EEF-F920C11EBF43Q50994717-8542D215-63B9-4963-A242-6BD45EE61615Q52667006-946A308A-887A-4514-A0A0-C4DF6FF3FA2EQ57770173-2E76FECF-B9AC-4ABE-A6FA-FBD4470D1E27
P2860
Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clobazam therapeutic drug moni ...... sals to improve future studies
@ast
Clobazam therapeutic drug moni ...... sals to improve future studies
@en
type
label
Clobazam therapeutic drug moni ...... sals to improve future studies
@ast
Clobazam therapeutic drug moni ...... sals to improve future studies
@en
prefLabel
Clobazam therapeutic drug moni ...... sals to improve future studies
@ast
Clobazam therapeutic drug moni ...... sals to improve future studies
@en
P2093
P2860
P1476
Clobazam therapeutic drug moni ...... sals to improve future studies
@en
P2093
Edoardo Spina
Francisco J Diaz
Jose de Leon
P2860
P356
10.1097/FTD.0B013E31827ADA88
P577
2013-02-01T00:00:00Z